Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DuPont de Nemours Inc (DD) vs Danaher Corporation (DHR) Price & Performance

DuPont de Nemours IncTrade
Danaher CorporationTrade

Price performance (Past 24H)

Key statistics

DuPont de Nemours Inc vs Danaher Corporation — how do they compare? DuPont de Nemours Inc trades at $134.7 (market cap $18.12B), while Danaher Corporation trades at $200.72 (market cap $140.88B). The key difference: Danaher Corporation is far larger — about 7.8× DuPont de Nemours Inc's market cap, and DuPont de Nemours Inc pays the higher dividend (1.79%). Which is the better fit depends on your goals.

DDDHR
Market Cap
$18.12B$140.88B
Sector
Basic MaterialsHealth
52-Week High
$154.59$242.05
52-Week Low
$87.72$161.91
Enterprise Value
$20.58B$153.66B
Dividend Yield
1.79%0.8%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DuPont de Nemours Inc

DuPont (DD) trades at $132.66, down 1.5% with bearish technical signals despite recent earnings beats. The stock shows mixed fundamentals with strong gross margins (35.01%) but negative net income margin (-0.42%) and ROE (-0.16%). Analyst consensus remains bullish with a $227.20 price target (71% upside), though the company faces legal challenges and persistent net cash outflows. Recent developments include water technology upgrades and a 3:1 reverse stock split effective June 2026.

While analyst optimism and valuation discount to price target suggest potential upside, investors face significant risks including ongoing litigation over 'forever chemicals,' weak profitability trends, and concerning cash flow patterns. The stock's current technical weakness near support levels requires careful monitoring of Q2 2026 earnings results due July 2026.

Danaher Corporation

Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.

The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DuPont de Nemours Inc

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.

Read more on DD

About Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.

Read more on DHR